BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32373131)

  • 41. Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3.
    Scheffold C; Kornacker M; Scheffold YC; Contag CH; Negrin RS
    Cancer Res; 2002 Oct; 62(20):5785-91. PubMed ID: 12384539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees.
    Ferrari G; Ottinger J; Place C; Nigida SM; Arthur LO; Weinhold KJ
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):647-56. PubMed ID: 8369169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.
    Mujib S; Liu J; Rahman AKMN; Schwartz JA; Bonner P; Yue FY; Ostrowski MA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies for prevention of mother-to-child transmission of HIV-1.
    Fouda GG; Moody MA; Permar SR
    Curr Opin HIV AIDS; 2015 May; 10(3):177-82. PubMed ID: 25700205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection.
    Gasper MA; Kunwar P; Itaya G; Lejarcegui N; Bosire R; Maleche-Obimbo E; Wamalwa D; Slyker J; Overbaugh J; Horton H; Sodora DL; John-Stewart G; Lohman-Payne B
    AIDS; 2014 May; 28(8):1115-24. PubMed ID: 24752082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.
    Legrand FA; Nixon DF; Loo CP; Ono E; Chapman JM; Miyamoto M; Diaz RS; Santos AM; Succi RC; Abadi J; Rosenberg MG; de Moraes-Pinto MI; Kallas EG
    PLoS One; 2006 Dec; 1(1):e102. PubMed ID: 17183635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
    Tasca S; Tambussi G; Nozza S; Capiluppi B; Zocchi MR; Soldini L; Veglia F; Poli G; Lazzarin A; Fortis C
    AIDS; 2003 Nov; 17(16):2291-8. PubMed ID: 14571180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
    Ahmad A; Menezes J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
    Gooneratne SL; Center RJ; Kent SJ; Parsons MS
    Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19
    Golay J; Martinelli S; Alzani R; Cribioli S; Albanese C; Gotti E; Pasini B; Mazzanti B; Saccardi R; Rambaldi A; Introna M
    Cytotherapy; 2018 Aug; 20(8):1077-1088. PubMed ID: 30093325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
    Wilson AD; Morgan AJ
    J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Tomalka AG; Resto-Garay I; Campbell KS; Popkin DL
    Front Immunol; 2018; 9():2552. PubMed ID: 30455699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection.
    Ferrari G; Haynes BF; Koenig S; Nordstrom JL; Margolis DM; Tomaras GD
    Nat Rev Drug Discov; 2016 Dec; 15(12):823-834. PubMed ID: 27725635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promotion of natural killer cell growth in vitro by bispecific (anti-CD3 x anti-CD16) antibodies.
    Malygin AM; Somersalo K; Timonen T
    Immunology; 1994 Jan; 81(1):92-5. PubMed ID: 7510664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treated HIV Infection Alters Phenotype but Not HIV-Specific Function of Peripheral Blood Natural Killer Cells.
    Zhao NQ; Ferreira AM; Grant PM; Holmes S; Blish CA
    Front Immunol; 2020; 11():829. PubMed ID: 32477342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma.
    Moore PA; Zhang W; Rainey GJ; Burke S; Li H; Huang L; Gorlatov S; Veri MC; Aggarwal S; Yang Y; Shah K; Jin L; Zhang S; He L; Zhang T; Ciccarone V; Koenig S; Bonvini E; Johnson S
    Blood; 2011 Apr; 117(17):4542-51. PubMed ID: 21300981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.